Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10-Q - License income
The value to PDS of the two reported licenses.....

During the 6 months ended November 30, 2015, PDS entered into licensing agreements with third parties, pursuant to which PDS received aggregate proceeds of $400,000 and $1,450,000, respectively.
Share
New Message
Please login to post a reply